Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,08
KB2,75
PKN71,9471,952,98
Msft437437,1-0,25
Nokia4,374,520,65
IBM249,26249,43-1,88
Mercedes-Benz Group AG50,9350,950,39
PFE22,4722,48-2,18
09.05.2025 17:36:58
Indexy online
AD Index online
select
AD Index online
 

  • 09.05.2025 17:36:17
Curaleaf Hldg Rg (US Other OTC (Pink Sheets))
Poslední obchod Změna (%) Změna (USD) Objem obchodů (ks)
0,84 -5,87 0,04 242 907
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 09.05.2025
Popis společnosti
Obecné informace
Název společnostiCuraleaf Holdings Inc
TickerCURA
Kmenové akcie:Ordinary Shares Subordinate Voting
Kmenové akcie:Ordinary Shares Multiple Voting
RICCURA.TO
ISIN-
Poslední známé roční výsledky31.12.2024
Poslední známé čtvrtletní výsledky31.12.2024
Počet zaměstnanců k 31.12.2024 5 519
Akcie v oběhu k 01.05.2025 757 152 232
MěnaUSD
Kontaktní informace
Ulice420 Lexington Avenue
MěstoNEW YORK
PSČ10170
ZeměUnited States
Kontatní osoba 
Funkce kontaktní osoby 
Telefon17 814 510 117

Business Summary: Curaleaf Holdings, Inc. is an international provider of consumer products in cannabis. The Company and its brands, including Curaleaf, Select, Grassroots, JAMS, Find and Zero Proof, provide service, product selection and accessibility across the medical and adult use markets. It has operations in about 17 states and operates 151 dispensaries, 19 cultivation sites and 20 manufacturing facilities, through which it sells cannabis through wholesale channels. The Company places a premium on populated, limited license states, including Arizona, Connecticut, Florida, Illinois, Maryland, Massachusetts, Nevada, New York, New Jersey, North Dakota, Ohio and Pennsylvania. It cultivates, processes, markets and/or dispenses a wide range of permitted cannabis products across its operating markets, including flowers, pre-rolls and flower pods, dry-herb vaporizer cartridges, concentrates for vaporizing, concentrates for dabbing, mints and lozenges, topical balms and lotions, tinctures, and others.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2024, Curaleaf Holdings Inc revenues decreased less than 1% to $1.34B. Net loss before extraordinary items decreased 9% to $209.6M. Revenues reflect Management fee income increase of 4% to $6.1M. Lower net loss reflects Other decrease of 71% to $14.6M (expense), Professional fees decrease of 37% to $24.4M (expense), Loss on disposal of assets increase from $8.5M (expense) to $4.6M (income).
Odvětvová klasifikace
TRBC2012Recreational Pharmaceuticals
MGINDUSTRYBiotechnology & Drugs
MGSECTORHealthcare
NAICSPharmaceutical Preparation Manufacturing
NAICS2007Medicinal & Botanical Mfg
NAICS1997Medicinal and Botanical Manufacturing
SICPharmaceutical Preparations



  • Poslední aktualizace: 09.05.2025
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chairman of the Board, Chief Executive OfficerBoris Jordan5716.08.2024
Executive Vice Chairman of the BoardJoseph Lusardi4901.01.2021
Chief Financial OfficerEdward Kremer5208.08.202208.08.2022
Chief People OfficerTyneeha Rivers46
Chief Investment OfficerCamilo Lyon4808.08.202208.08.2022
Chief Compliance OfficerJames Shorris63
Chief Legal OfficerPeter Clateman55